Sexually dimorphic activation of innate antitumour immunity prevents adrenocortical carcinoma development
J. J. Wilmouth, J. Olabe, D. Garcia-Garcia, C. Lucas, R. Guiton, F. Roucher-Boulez, D. Dufour, C. Damon-Soubeyrand, I. Sahut-Barnola, J.-C. Pointud, Y. Renaud, A. Levasseur, I. Tauveron, A.-M. Lefrancois-Martinez, A. Martinez, P. Val
This study shows that sexually dimorphic activation of innate antitumour immunity prevents adrenocortical carcinoma development, with male-specific macrophage responses driving tumour regression.
bioRxiv · Apr 29, 2022 · PreprintCancer Biology